Skip to main content
Monday, August 24, 2026
BTC $78,882 ▲ 1.47%
GOKHSHTEIN.
Live WirePoliticsWorldMarketsDigital AssetsTechnologySports
FranchisesThe BriefThe Big ReadThe BreakdownCrypto Culture
More SectionsDeFi & On-ChainU.S. EquitiesMacro & RatesResearch
Subscribe
Menu
NewsLive WirePoliticsWorldMarketsDigital AssetsTechnologySports
FranchisesThe BriefThe Big ReadThe BreakdownCrypto Culture
MoreDeFi & On-ChainU.S. EquitiesMacro & RatesResearch
Subscribe
LIVE
ADA$0.220down−2.91%ETH$2,474up+0.44%LINK$11.55up+0.09%SOL$95.69up+0.28%BTC$78,882up+1.47%XRP$1.48down−2.40%S&P 5007,654down−0.26%Nasdaq26,032down−0.57%Dow53,346up+0.13%RUT2,993down−0.83%TNX4.70%down−0.80%TYX5.23%down−0.89%FVX4.40%down−0.43%IRX3.71%down−0.08%VIX15.80up+4.43%GOLD$4,691.60up+0.24%SILVER$68.40down−1.63%OIL$84.74down−2.66%DXY99.05up+0.26%NVDA$209.82down−2.28%AAPL$311.86up+0.81%TSLA$354.07down−2.42%META$556.81up+1.26%MSFT$487.98up+0.98%AMZN$262.21up+1.38%GOOGL$348.72up+1.13%Fear & Greed73 — GreedADA$0.220down−2.91%ETH$2,474up+0.44%LINK$11.55up+0.09%SOL$95.69up+0.28%BTC$78,882up+1.47%XRP$1.48down−2.40%S&P 5007,654down−0.26%Nasdaq26,032down−0.57%Dow53,346up+0.13%RUT2,993down−0.83%TNX4.70%down−0.80%TYX5.23%down−0.89%FVX4.40%down−0.43%IRX3.71%down−0.08%VIX15.80up+4.43%GOLD$4,691.60up+0.24%SILVER$68.40down−1.63%OIL$84.74down−2.66%DXY99.05up+0.26%NVDA$209.82down−2.28%AAPL$311.86up+0.81%TSLA$354.07down−2.42%META$556.81up+1.26%MSFT$487.98up+0.98%AMZN$262.21up+1.38%GOOGL$348.72up+1.13%Fear & Greed73 — Greed
GOKHSHTEIN.
Media · Est. 2019
The front page of everything. Breaking news and sharp analysis across politics, markets, crypto, technology, and sports — with live market data built in.
Markets
Market OverviewDigital AssetsU.S. EquitiesMacro & RatesResearch
Editorial
Politics & PolicyTechnologySports BusinessResearch
Terminal
GMarketsGo PRO
Company
AboutContactThe NetworkEditorial StandardsCorrectionsAdvertiseSubscribe
Legal
Privacy PolicyTerms of ServiceDisclosures
© 2026 Gokhshtein Media. All rights reserved.
PrivacyTermsDisclosures
Tag

Biotechnology

3 articles

Moderna Surges 177% on Melanoma Vaccine Win; Wall Street Raises Targets
U.S. EquitiesYesterday
Moderna Surges 177% on Melanoma Vaccine Win; Wall Street Raises Targets
Moderna stock soared on positive Phase 3 results for its personalized melanoma vaccine with Merck, prompting Morgan Stanley to raise its price target to $89 from $39.
AI-Bioweapons Risk Forces U.S. Action on New Security Threat
Politics & Policy3d ago
AI-Bioweapons Risk Forces U.S. Action on New Security Threat
Artificial intelligence is lowering the barriers to biological weapons development, prompting national security officials to push for urgent policy changes.
CRISPR Therapeutics' Gene Revolution: A Foundational Bet on National Health
U.S. Equities130d ago
CRISPR Therapeutics' Gene Revolution: A Foundational Bet on National Health
America's historical commitment to public health, exemplified by smallpox inoculation, now underpins a compelling investment thesis for innovative biotech firms driving national economic vitality.